Pediatric Bioscience Selected as "Top Presenting Company" at 2007 Golden Capital Sacramento Region Venture Capital Conference.One of Two Companies out of 28 to Be Selected SACRAMENTO, Calif. -- Pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. Bioscience LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , today announced that it has been selected as a "Top Presenting Company," at the recent 2007 Golden Capital Network Sacramento Region Venture Capital Conference. Pediatric Bioscience was formed in 2006 by a group of researchers, parents and experienced business leaders with the goal of bringing to market diagnostics and therapeutics to predict, diagnose and eventually treat children with autism autism (ô`tĭzəm), developmental disability resulting from a neurological disorder that affects the normal functioning of the brain. It is characterized by the abnormal development of communication skills, social skills, and reasoning. . "This is a big step towards our goal of raising the necessary funding to bring our first diagnostic products to market," said Dr. Thomas R. Anderson, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Pediatric Bioscience. "These products will help the millions of families affected by the growing incidence of autism. The Golden Capital Network conference allowed us to present our vision directly to prospective investors that may be able to help us realize that goal." Pediatric Bioscience has licensed three promising discoveries of the UC Davis M.I.N.D. Institute, a multidisciplinary research center striving to find causes, improved treatments and ultimately cures for neurodevelopmental disorders Neurodevelopmental disorders such as fragile X syndrome are severe disabling conditions often associated with life-long impairment. History These disorders are now recognized to be the result of abnormalities in brain development due to both genetic and . The licensed technologies include a prenatal prenatal /pre·na·tal/ (-na´tal) preceding birth. pre·na·tal adj. Preceding birth. Also called antenatal. prenatal preceding birth. assessment of increased risk of delivering a child with autism by detecting certain auto-antibodies in the blood of the prospective mothers, and a method for detecting autism biochemically, rather than by observed behavior, allowing for much earlier identification of children with autism. "Dr. Anderson captured the hearts and imaginations of the assembled investors," said Jon Gregory, Golden Capital Network's president and CEO. "28 companies presented their plans for success and Pediatric Bioscience rose to the top of a very promising group of companies." For more information about the Golden Capital Network, please visit www.goldencapital.net About Pediatric Bioscience Pediatric Bioscience LLC was formed in 2006 by a group of researchers, parents and experienced business leaders with the goal of bringing to market diagnostics and therapeutics to diagnose and eventually treat children with autism. The company is based in Sacramento, California “Sacramento” redirects here. For other uses, see Sacramento (disambiguation). Sacramento is the capital of the State of California and the county seat of Sacramento County. . For more information about Pediatric Bioscience, please visit www.pediatricbioscience.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion